Further, all-trans-retinoic acid (ATRA) treatment of the neuroblastoma cell line CHP134 predominantly induced expression of TAp63 but decreased expression of p53 and TAp73; meanwhile, the expression of MYCN is downregulated by TAp63 directly and indirectly through NCYM [47]. The gene discussed is TP53; the disease is neuroblastoma.